Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

Background: Due to the lack of protective immunity of humans towards the newly emerged SARS-CoV-2, this virus has caused a massive pandemic across the world resulting in hundreds of thousands of deaths. Thus, a vaccine is urgently needed to contain the spread of the virus. Methods: Here, we describe...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Weina Sun, Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva, Fatima Amanat, Alexandra Schäfer, Kenneth H. Dinnon, III, Adolfo García-Sastre, Florian Krammer, Ralph S. Baric, Peter Palese
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-12-01
coleção:	EBioMedicine
Assuntos:	Viral vector vaccine Intramuscular administration Neutralizing antibodies Mouse-adapted SARS-CoV-2 Live COVID-19 vaccine Coronavirus vaccine
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352396420305089
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!